A atuação do farmacêutico no uso da semaglutida (Ozempic): uma revisão integrativa
JC do Nascimento, WMG Lima… - Brazilian Journal of …, 2021 - ojs.brazilianjournals.com.br
A maioria dos pacientes com diabetes tipo 2, além de mudanças nos hábitos diários,
necessita de medicamentos para controlar a doença. Desse modo, um dos medicamentos …
necessita de medicamentos para controlar a doença. Desse modo, um dos medicamentos …
The cost-effectiveness of subcutaneous semaglutide versus empagliflozin in type 2 diabetes uncontrolled on metformin alone in Denmark
LH Ehlers, M Lamotte, MC Ramos, S Sandgaard… - Diabetes Therapy, 2022 - Springer
Abstract Introduction International and Danish guidelines recommend the use of glucagon-
like peptide 1 receptor agonists (GLP-1 RA) and sodium–glucose cotransporter 2 (SGLT-2) …
like peptide 1 receptor agonists (GLP-1 RA) and sodium–glucose cotransporter 2 (SGLT-2) …
[HTML][HTML] Overview of type 2 Diabetes Drugs on the market
Y Hu, Y Chen - Journal of Biosciences and Medicines, 2020 - scirp.org
Type 2 Diabetes Mellitus (T2DM) is a systemic metabolic disorder with complex
pathogenesis. In recent years, a variety of new T2DM drugs have emerged, such as sodium …
pathogenesis. In recent years, a variety of new T2DM drugs have emerged, such as sodium …
Jordanian Population Knowledge, Attitude and Practices on the Uses of Antidiabetics for Weight Loss Purposes: A Cross Sectional Study
R Abutaima, M Barakat, HA Sawan, S ALomari… - 2023 - researchsquare.com
Background Obesity became a recent pandemic, especially, during the Corona Virus
Pandemic of 2019 (COVID-19) lockdown. Therefore, people started to adopt effortless …
Pandemic of 2019 (COVID-19) lockdown. Therefore, people started to adopt effortless …
Ozempic no emagrecimento: um novo paradigma no tratamento da Obesidade
PRPF de Oliveira, MB Siqueira… - Caderno …, 2024 - ojs.studiespublicacoes.com.br
A obesidade é uma condição crônica multifatorial, associada a comorbidades como
diabetes tipo 2, doenças cardiovasculares e disfunções metabólicas. O tratamento eficaz da …
diabetes tipo 2, doenças cardiovasculares e disfunções metabólicas. O tratamento eficaz da …
Diabetic Management with GLP1-RA Ozempic and Diabetic Education
K Sivo-Souza - 2024 - digitalcommons.liberty.edu
A condition with observed poor management by most who possess a diagnosis, diabetes
mellitus remains the seventh leading cause of death within the country. This diagnosis can …
mellitus remains the seventh leading cause of death within the country. This diagnosis can …
[PDF][PDF] The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark
LHEML Mafalda, CRS Sandgaard - 2022 - academia.edu
ABSTRACT Introduction: International and Danish guidelines recommend the use of
glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium–glucose cotransporter 2 …
glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium–glucose cotransporter 2 …
Drug Pipeline for Obesity Therapy 68
AT Panicker, P Desai, S Karnik, MS Kumar - Obesity and Diabetes, 2020 - Springer
Obesity contributes more to the mortality rates than malnourishment in countries with the
majority of the world's population. First-line methods with lifestyle modifications may not be …
majority of the world's population. First-line methods with lifestyle modifications may not be …
Drug Pipeline for Obesity Therapy
AT Panicker, P Desai, S Karnik, MS Kumar - Obesity and Diabetes …, 2020 - Springer
Obesity contributes more to the mortality rates than malnourishment in countries with the
majority of the world's population. First-line methods with lifestyle modifications may not be …
majority of the world's population. First-line methods with lifestyle modifications may not be …